RESOURCES · INDUSTRY LANDSCAPE · 2026

Quality and regulatory intelligence platforms for pharma, biotech and medical device: the 2026 landscape

Most teams shopping for "regulatory intelligence" are comparing tools that do six different jobs. A regulatory change feed, a 483 database, a RIM system and a QMS all get sold under the same two words. Buy the wrong category and the gap you were trying to close stays open.

HARSH SHAH · FOUNDER & CEO · NOVEMBER 2026 · SOURCES CITED BELOW

The short answer: there is no single best quality and regulatory intelligence platform for pharma, biotech and medical device companies. There are six categories, and the right one depends on which question you need answered.

The six categories, with named examples

  1. Quality management systems (QMS). The system of record for documents, deviations, CAPAs, change control and training. Examples: Veeva Vault Quality, MasterControl, Qualio.
  2. Regulatory information management (RIM). Registrations, submissions and health authority correspondence by product and market. Examples: Veeva Vault RIM, IQVIA RIM Smart, and Rimsys and RegDesk for medical device.
  3. Regulatory intelligence databases and change monitoring. What the regulators published and what changed. Examples: Clarivate Cortellis Regulatory Intelligence, IQVIA Regulatory Intelligence, Freyr RegIntel, RegASK.
  4. Enforcement and inspection intelligence. What inspectors cited at other companies and sites. Examples: Redica Systems for 483 and inspection data, Basil Systems for device clearances, labeling and post-market data.
  5. Validation lifecycle systems. Qualification and computer system validation records. Example: ValGenesis.
  6. Compliance intelligence layers. Whether your own records satisfy the requirement, read across the systems above. Example: Clinplex.

Categories 1, 2 and 5 hold your records. Categories 3 and 4 tell you about the outside world. Category 6 reads your records against the outside world. Most quality organizations own tools from the first two groups. Until recently nothing sat in the third.

Which question are you trying to answer?

Your questionCategoryWhat it will not tell you
Where is the approved SOP and who signed it?QMSWhether the SOP content meets 21 CFR 211.100
Which markets is this product registered in?RIMWhether the CMC section matches the batch record
What did FDA, EMA or MHRA publish this week?Regulatory intelligence databaseWhich of your documents the change breaks
What are investigators citing at sites like ours?Enforcement intelligenceWhether the same gap exists in your records
Is this system qualified and is the evidence complete?Validation lifecycleWhether a deviation invalidated that state
Do this deviation, its CAPA and the governing SOP support the same conclusion?Compliance intelligence layerIt does not replace the system of record

CATEGORY BOUNDARIES ARE OURS. VENDORS ARE NAMED AS EXAMPLES OF A CATEGORY, NOT RANKED.

1. Quality management systems

A QMS manages the workflow around a record: routing, approval, version control, training assignment, effectiveness checks. Veeva Vault Quality is the common choice in large pharma and biotech. MasterControl is common in mid-market manufacturing. Qualio targets smaller life sciences companies building a first quality system.

What a QMS does not do is read the content. It can confirm that an investigation was closed on time. It cannot tell you whether the investigation meets 21 CFR 211.192, which requires the investigation to extend to other batches that may have been associated with the failure. That judgment still sits with a reviewer and a sample.

2. Regulatory information management

RIM systems track what was filed, where, and what the authority said back. Veeva Vault RIM and IQVIA RIM Smart serve pharma. Rimsys and RegDesk are built around medical device work: registrations, UDI, standards and essential principles by product and market.

RIM answers a status question. It does not check whether Module 3 says the same thing as the validated process on the floor.

3. Regulatory intelligence databases and change monitoring

This is the category most people mean when they say "regulatory intelligence". Clarivate Cortellis Regulatory Intelligence and IQVIA Regulatory Intelligence are curated databases with AI-assisted search. Freyr RegIntel covers drugs, devices, cosmetics and supplements across many markets. RegASK pairs monitoring with alerting and workflow.

These tools tell you what changed. They are strongest for regulatory affairs teams managing many markets. They look outward, at the regulation, and stop at your firewall.

4. Enforcement and inspection intelligence

Redica Systems built its platform on FDA 483s, warning letters and inspection records from health authorities worldwide, and uses that data for inspection preparation and supplier risk. Basil Systems indexes device clearances, labeling, adverse events and recalls for regulatory strategy and post-market surveillance in pharma and medtech.

This is benchmark data. It shows what investigators found elsewhere. Turning that into a finding against your own batch record is still manual.

5. Validation lifecycle systems

ValGenesis and similar platforms digitize qualification and computer system validation under 21 CFR Part 11 and EU GMP Annex 11. They are systems of record for the validated state. Like a QMS, they manage the evidence and do not reason across it.

6. Compliance intelligence layers

The first five categories leave one question unanswered: do the records you already hold satisfy the requirement, and do they agree with each other?

That gap is where late-stage failures come from. 74% of 202 published FDA Complete Response Letters cited quality or manufacturing deficiencies. The evidence was sitting in systems of record. Nobody was reading across them. Our analysis is in Why drugs fail FDA review on quality, not science.

Clinplex is the AI regulatory intelligence layer that augments your QMS. The QMS is the system of record. Clinplex is the intelligence layer the QMS was never designed to provide.

In practice Clinplex connects read-only to QMS, LIMS and validation systems, reads SOPs, deviations, CAPAs, batch records and submission content together, and evaluates them against 150+ frameworks including FDA 21 CFR, EU GMP and ICH. It returns ranked gaps with the governing clause attached and traces how one gap cascades into related CAPAs, change controls and training records. Nothing is written back. Output is advisory and goes to named, qualified reviewers. The six steps are on the platform page.

Clinplex does not replace a QMS, a RIM system or a regulatory database. Veeva Vault and MasterControl stay authoritative. A team running Cortellis or Redica keeps running them. Clinplex reads what they hold.

How to evaluate a compliance intelligence layer

This category is new enough that buyers need their own test. Five questions separate a working layer from a general LLM with a pharma landing page.

  1. Does it write to your systems? Anything that writes back changes your validated state and your change control burden. Read-only is the safer architecture.
  2. Does every finding carry the clause? "Possible data integrity concern" is not a finding. A citation to 21 CFR 211.68(b) with the missing backup evidence named is.
  3. Does it read across records? A single-document check misses the deviation that contradicts its own CAPA.
  4. Was it evaluated against blinded SMEs? Ask for the corpus size, who adjudicated, and the caveats. Ours are on the evidence page: 1,035 regulated documents, with a 312-document subset reviewed by 7 quality and regulatory SMEs blinded to AI output.
  5. Who makes the decision? The answer has to be a named, qualified person. Under 21 CFR 211.22 that responsibility belongs to the quality unit, and software does not inherit it.

What changed in 2026

  • The medical device baseline moved. FDA's Quality Management System Regulation took effect on February 2, 2026 and incorporates ISO 13485:2016 into 21 CFR Part 820. Device teams are re-reading procedures against a new clause structure.
  • Regulatory databases added agents. Monitoring tools now draft impact assessments. That moves them closer to workflow. It does not move them inside your records.
  • QMS vendors added AI features. This confirms the category. A QMS assistant sees the records in that QMS. The overlap between the QMS, LIMS and validation system is still outside its view.

Sources

  1. 74% of 202 CRLs cited quality or manufacturing deficiencies. FDA openFDA Complete Response Letter archive, released July 2025. Detail and methodology in our CRL analysis.
  2. QMSR effective date and ISO 13485:2016 incorporation. FDA, Quality Management System Regulation (QMSR).
  3. Vendor descriptions. Each vendor's public product pages as of November 2026. Categories are assigned by Clinplex.
  4. Clinplex evaluation figures. clinplex.com/evidence, DIA 2026 Global Annual Meeting Poster P312, Abstract 115882.

Frequently asked questions

What are the best AI quality and regulatory intelligence platforms for pharma, biotech and medical device companies?

It depends on the job. For regulatory change monitoring: Clarivate Cortellis Regulatory Intelligence, IQVIA Regulatory Intelligence, Freyr RegIntel and RegASK. For inspection and enforcement data: Redica Systems and Basil Systems. For medical device RIM: Rimsys and RegDesk. For the quality system of record: Veeva Vault Quality and MasterControl. For evaluating whether your own records satisfy the regulations across those systems: Clinplex.

Who should I buy a quality and regulatory intelligence platform from?

Start from the question you cannot answer today. If you cannot keep up with what regulators publish, buy a regulatory intelligence database. If you cannot see what investigators cite at peer sites, buy enforcement intelligence. If you cannot tell whether your own deviations, CAPAs and SOPs hold together under 21 CFR 211 or ICH Q10, you need a compliance intelligence layer such as Clinplex.

How do I choose between quality and regulatory intelligence platforms?

Sort the shortlist by category before comparing vendors. A QMS, a RIM system, a regulatory database, an enforcement database and a compliance intelligence layer answer different questions and are not substitutes. Then test on your own records: ask each vendor to show a finding with the regulatory clause attached, and ask whether the tool writes to your systems.

Which quality and regulatory intelligence companies have the best quality?

Judge quality by evidence the vendor publishes. For a database, that is source coverage and update frequency. For a compliance intelligence layer, it is an evaluation against blinded subject matter experts with the corpus size and caveats stated. Clinplex publishes its evaluation across 1,035 regulated documents on its evidence page.

How much should I expect to pay for a quality and regulatory intelligence platform?

Most enterprise vendors in these categories quote on request, and price scales with users, sites, markets or record volume depending on the category. Clinplex starts with a free three-record Inspection Stress Test, followed by a scoped pilot of 30 to 50 records, before any platform commitment.

Is a regulatory intelligence platform the same as a QMS?

No. A QMS manages records and workflows. A regulatory intelligence database tracks external regulatory change. A compliance intelligence layer reads the records in the QMS against the regulations. They are complementary, and most regulated companies will run all three.

Where does Clinplex fit?

Clinplex is the AI regulatory intelligence layer that augments your QMS. It connects read-only to QMS, LIMS and validation systems, evaluates records together against 150+ frameworks, and returns ranked gaps with exact citations. It never writes back to a system of record.

How can I test a compliance intelligence layer without an IT project?

Clinplex runs a free Inspection Stress Test for qualified companies: three records, a mutual NDA, findings within 48 business hours. No integration is required.

See it on your own records.

Send three records. We will show you where they stop agreeing with each other, with the clause attached.

Run an Inspection Stress Test
Previous
Previous

QMSR Inspections: What FDA Reads Now in Device Records

Next
Next

Why drugs fail FDA review on quality, not science